WestfallTCMacarthurHWestfallDP. Adrenergic agonists and antagonists. In: BruntonLLHilal-DandanRKnollmannBC, eds. Goodman and Gilman’s: the Pharmacological Basis of Therapeutics. 13th ed.New York, NY: McGraw-Hill Education; 2017:191-224.
2.
MontastrucFMontastrucGMontastrucJLRevetA.Cardiovascular safety of methylphenidate should also be considered in adults. BMJ. 2016;353:i3418. doi:10.1136/bmj.i34418
3.
HornJRHanstenPDChanLN.Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674-680. doi:10.1345/aph.1H423
4.
EhrhardtCBoucherieQPaulyV, et al. Methylphenidate: gender trends in adult and pediatric populations over a 7 year period. Therapie. 2017;72:635-641. doi:10.1016/j.therap.2017.05.005
5.
DupuiMMicallefJLapeyre-MestreM.Interest of large electronic health care databases in addictovigilance: lessons from 15 years of pharmacoepidemiological contribution. Therapie. 2019;74:307-314. doi:10.1016/j.therap.2018.09.078
